Remdesivir versus Standard of Care in Moderate to Severe COVID-19 Patients: A Retrospective Study
Introduction: In December 2019, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a novel coronavirus, was first identified as the cause of a respiratory illness designated Coronavirus Disease 2019 (COVID-19). Since then, several antiviral drugs have been evaluated for the treatment o...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2021-04-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/14767/48386_CE[Ra1]_F[SK]_PF1(AG_SL)_PFA(KM)_PB(AG_KM)_PN(KM).pdf |